Clinical Trial Update: Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial of a 13-valent pneumococcal conjugate vaccine in infants is currently active but not recruiting, sponsored by Fosun Adagenvax Biopharmaceutical …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) (Pneumococcal conjugate vaccine (13-valent))

Snippet

Sponsor: Fosun Adgenvax Biopharmaceutical Co.,Ltd. | Conditions: Streptococcus Pneumoniae Infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING